Axon Enterprise, Inc. - AXON
CEO
Director
CHIEF EXECUTIVE OFFICER
Direct Buys
0
$0
0
Shares
Direct Sells
2
($7.34) M
-14,767
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
04/21/2025
10b5-1
|
04/23/2025 |
Sell
|
-10,000 @ $540.99
|
($5,409,861) | 3,063,982 (-0.33%) | Direct |
|
10/03/2024
10b5-1
|
10/04/2024 |
Sell
|
-4,767 @ $404.14
|
($1,926,545) | 2,925,060 (-0.16%) | Direct |
Oncocyte Corp - OCX
10% owner
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
8
$2.45 M
1,188,987
Shares
Indirect Sells
0
$0
0
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
02/07/2025
|
02/11/2025 |
Buy
|
1,077,600 @ $2.05
|
$2,209,080 | 2,872,671 (60.03%) | Indirect - See footnote |
|
02/04/2025
|
02/04/2025 |
Buy
|
25 @ $2.02
|
$50 | 1,795,071 (0.00%) | Indirect - See footnote |
|
01/31/2025
|
02/04/2025 |
Buy
|
890 @ $2.01
|
$1,789 | 1,795,046 (0.05%) | Indirect - See footnote |
|
01/30/2025
|
01/31/2025 |
Buy
|
318 @ $2.01
|
$639 | 1,794,156 (0.02%) | Indirect - See footnote |
|
01/29/2025
|
01/31/2025 |
Buy
|
3,880 @ $2.01
|
$7,799 | 1,793,838 (0.22%) | Indirect - See footnote |
|
01/14/2025
|
01/15/2025 |
Buy
|
10,386 @ $2.15
|
$22,323 | 1,789,958 (0.58%) | Indirect - See footnote |
|
01/13/2025
|
01/15/2025 |
Buy
|
5,669 @ $2.08
|
$11,792 | 1,779,572 (0.32%) | Indirect - See footnote |
|
12/26/2024
|
12/27/2024 |
Buy
|
90,219 @ $2.13
|
$192,166 | 1,773,903 (5.36%) | Indirect - See footnote |